[Medium-term tolerance of anterior chamber implants in surgical treatment of severe myopia].
OBJECTIVE
To determine the tolerance of the corneal endothelium and of the haemato-ocular barrier of phakic highly myopic eyes implanted with an anterior chamber I.O.L.ses.


METHODS
Twenty-one phakic highly myopic were operated on with a Z.B.A.C.I.O.L. (manufactured by Domilens) by the same surgeon from May 1989 to June 1990. Complete examination including specular microscopy have been performed before surgery and each 6 months and a Laser Flare Cell Meter at 3 years was performed on 14 eyes.


RESULTS
Two eyes of the same patient had to be explanted after surgery for important endothelial cell loss. The 19 others had no complication: no cataract, no loss of endothelial cells, no retinal detachment. 14 eyes examined with a Laser Cell Flare Meter had results within normal limits. So, 19 out of 21 eyes implanted for high myopia with Z.B.A.C.I.O.L. have excellent results 4 years after surgery.


CONCLUSIONS
Regarding these results, it seems possible to use this technique again with the new designed Anterior Chamber I.O.L.. Rigorous follow-up of all the implanted eyes is however required.
Leroux les Jardins
S
S
Hôpital des Quinze-Vingts, Paris.
Heligon
J P
JP
Ozdemir
N
N
Pasquier
N
N
Le Hoang
P
P
D000328:Adult; D000867:Anterior Chamber; D001813:Blood-Retinal Barrier; D002452:Cell Count; D004728:Endothelium, Corneal / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007910:Lenses, Intraocular / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009216:Myopia / Q000601:surgery*; D013997:Time Factors
Tolérance à moyen terme des implants myopiques de chambre antérieure dans le traitement chirurgical de la myopie forte.